Medications such as semaglutide (Ozempic) and tirzepatide (Mounjaro), which affect appetite and reward pathways, are now being investigated as pharmacological adjuncts to help people reduce or ...

The molecule is semaglutide, and it's sold under the name Ozempic for type 2 diabetes and Wegovy for weight loss -- but doctors have prescribed either for weight management. And this has made Novo ...

The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout for counterfeit Ozempic (semaglutide) and to refrain from using the ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...

Five GLP-1RAs are available in the UK-dulaglutide, exenatide, liraglutide, lixisenatide, and semaglutide, which is the active ingredient in Ozempic and Wegovy. Ozempic is not marketed as a weight ...

Ozempic (semaglutide) and metformin are prescription drugs that are both used to help manage blood sugar levels in people with type 2 diabetes. Ozempic is a brand-name drug, while metformin is a ...

or if they were taking compounded semaglutide. Compounded medications are not FDA-approved and are prepared by pharmacists. They also typically come in vials instead of injection pens, meaning ...